Document is current
Any future updates will be listed below
-
Authors
Passeron, Thierry https://orcid.org/0000-0002-0797-6570
Brown, Anthony https://orcid.org/0000-0002-1271-310X
Furmanczyk, Marta https://orcid.org/0000-0003-3524-514X
Foyaca, Monica
Trullas, Carles https://orcid.org/0000-0003-1925-5102
Piquero-Casals, Jaime https://orcid.org/0000-0002-4481-5602
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn11448711 at ISRCTN.orgDocuments that mention this clinical trial
An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen Containing Sclareolide and Niacinamide for the Prevention of Post-inflammatory Hyperpigmentation in Skin of Color
https://doi.org/10.1007/s13555-025-01586-w
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 27 October 2025
First Online: 15 November 2025
Declarations
:
: Thierry Passeron and Jaime Piquero-Casals serve as consultants for ISDIN. Anthony Brown, Carles Trullas, Marta Furmanczyk, and Monica Foyaca are employees of ISDIN.
: The study protocol (2023-A02785-40) was reviewed and approved by an appropriate IEC (Comité de Protection des Personnes (CPP) Ouest III) on 13 May 2024 and was conducted in accordance with the ethical principles initially outlined in the Declaration of Helsinki and its subsequent amendments and Good Clinical Practice (GCP). All subjects who participated in this clinical study were fully informed about the clinical study, and prior to inclusion, the subject and the investigator signed and dated the consent form(s).
